Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1994;89:1254-1261

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Richard, V.
Right arrow Articles by Thuillez, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Richard, V.
Right arrow Articles by Thuillez, C.

Circulation, Vol 89, 1254-1261, Copyright © 1994 by American Heart Association


ARTICLES

Ischemic preconditioning protects against coronary endothelial dysfunction induced by ischemia and reperfusion

V Richard, N Kaeffer, C Tron and C Thuillez
Department of Pharmacology, Rouen University School of Medicine, France.

BACKGROUND: Repetitive, brief periods of ischemia and reperfusion ("preconditioning") increase the resistance of myocardial tissue to subsequent prolonged ischemic episodes and limit infarct size. We investigated whether preconditioning also protects against coronary endothelial dysfunction induced by ischemia and reperfusion. METHODS AND RESULTS: Experiments were performed in four groups of rats (n = 8 in each group): group 1 rats underwent sham surgery, group 2 rats were subjected to 20 minutes of left coronary artery occlusion without reperfusion, group 3 rats underwent 20 minutes of occlusion followed by 1 hour of reperfusion, and group 4 rats (preconditioning group) underwent the same protocol as group 3 rats, preceded by three cycles of 5 minutes of ischemia and 5 minutes of reperfusion. At the end of the experiments, coronary segments (internal diameter, 250 to 300 microns) were removed distal to the occlusion site and mounted in wire myographs for isometric tension recording. Relaxations induced by increasing concentrations of acetylcholine, the calcium ionophore A23187, or the nitric oxide (NO) donor SIN-1 were determined in arteries precontracted by serotonin. Basal NO release was estimated by measuring contractions to NG-nitro L-arginine methyl ester (L-NAME). In addition, we determined the effect of preconditioning on infarct size in two additional groups that were subjected to the same protocols as those of groups 3 and 4. In those animals, area at risk (India ink injection) and infarct size (triphenyltetrazolium stain) were determined by computerized analysis of enlarged sections after video acquisition. Preconditioning markedly limited infarct size (percent of area at risk: controls, 57 +/- 2; preconditioning, 2.2 +/- 0.6; P < .01). Ischemia (without or with reperfusion) or preconditioning did not affect the coronary responses to L-NAME, serotonin, A23187, or SIN-1. Ischemia without reperfusion did not modify the relaxations to acetylcholine (maximal relaxation: sham, 58 +/- 4%; ischemia, 56 +/- 7%; P = NS). In contrast, ischemia followed by reperfusion markedly impaired the response to acetylcholine (26 +/- 6%; P < .01 versus sham). This impaired response was restored by preconditioning (maximal relaxation: 59 +/- 9%; P = NS versus sham; P < .01 versus ischemia/reperfusion). CONCLUSIONS: In addition to protecting myocardial cells, preconditioning also protects coronary endothelial cells against ischemia/reperfusion injury.


This article has been cited by other articles:


Home page
LupusHome page
C Belizna, A Lartigue, J Favre, D Gilbert, F Tron, H Levesque, C Thuillez, and V Richard
Antiphospholipid antibodies induce vascular functional changes in mice: a mechanism of vascular lesions in antiphospholipid syndrome?
Lupus, March 1, 2008; 17(3): 185 - 194.
[Abstract] [PDF]


Home page
CirculationHome page
M.-L. Ambroisine, J. Favre, P. Oliviero, C. Rodriguez, J. Gao, C. Thuillez, J.-L. Samuel, V. Richard, and C. Delcayre
Aldosterone-Induced Coronary Dysfunction in Transgenic Mice Involves the Calcium-Activated Potassium (BKCa) Channels of Vascular Smooth Muscle Cells
Circulation, November 20, 2007; 116(21): 2435 - 2443.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
A. Agouni, H. A. Mostefai, C. Porro, N. Carusio, J. Favre, V. Richard, D. Henrion, M. C. Martinez, and R. Andriantsitohaina
Sonic hedgehog carried by microparticles corrects endothelial injury through nitric oxide release
FASEB J, September 1, 2007; 21(11): 2735 - 2741.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
W. J. Pearce
Cerebrovascular effects of ischemic preconditioning: endothelial survivin joins the fray
Am J Physiol Heart Circ Physiol, June 1, 2007; 292(6): H2559 - H2560.
[Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
J. Favre, P. Musette, V. Douin-Echinard, K. Laude, J.-P. Henry, J.-F. Arnal, C. Thuillez, and V. Richard
Toll-Like Receptors 2-Deficient Mice Are Protected Against Postischemic Coronary Endothelial Dysfunction
Arterioscler Thromb Vasc Biol, May 1, 2007; 27(5): 1064 - 1071.
[Abstract] [Full Text] [PDF]


Home page
Exp PhysiolHome page
C. Carrasco-Martin, S. Alonso-Orgaz, J. C De la Pinta, M. Marques, C. Macaya, A. Barrientos, M. M Gonzalez, A. Garcia-Mendez, P. J. Mateos-Caceres, J. C Porres, et al.
Endothelial hypoxic preconditioning in rat hypoxic isolated aortic segments
Exp Physiol, July 1, 2005; 90(4): 557 - 569.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
S. G. De Hert, F. Turani, S. Mathur, and D. F. Stowe
Cardioprotection with Volatile Anesthetics: Mechanisms and Clinical Implications
Anesth. Analg., June 1, 2005; 100(6): 1584 - 1593.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
J. Feng, C. Bianchi, J. Li, and F. W. Sellke
Bradykinin Preconditioning Preserves Coronary Microvascular Reactivity During Cardioplegia-Reperfusion
Ann. Thorac. Surg., March 1, 2005; 79(3): 911 - 916.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
A. Beresewicz, M. Maczewski, and M. Duda
Effect of classic preconditioning and diazoxide on endothelial function and O2- and NO generation in the post-ischemic guinea-pig heart
Cardiovasc Res, July 1, 2004; 63(1): 118 - 129.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
K. Laude, J. Favre, C. Thuillez, and V. Richard
NO produced by endothelial NO synthase is a mediator of delayed preconditioning-induced endothelial protection
Am J Physiol Heart Circ Physiol, June 1, 2003; 284(6): H2053 - H2060.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
K. Laude, C. Thuillez, and V. Richard
Peroxynitrite triggers a delayed resistance of coronary endothelial cells against ischemia-reperfusion injury
Am J Physiol Heart Circ Physiol, October 1, 2002; 283(4): H1418 - H1423.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
K. Laude, P. Beauchamp, C. Thuillez, and V. Richard
Endothelial protective effects of preconditioning
Cardiovasc Res, August 15, 2002; 55(3): 466 - 473.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
P. G. McLean, D. Aston, D. Sarkar, and A. Ahluwalia
Protease-Activated Receptor-2 Activation Causes EDHF-Like Coronary Vasodilation: Selective Preservation in Ischemia/Reperfusion Injury: Involvement of Lipoxygenase Products, VR1 Receptors, and C-Fibers
Circ. Res., March 8, 2002; 90(4): 465 - 472.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
T. Reffelmann and R. A Kloner
The "no-reflow" phenomenon: basic science and clinical correlates
Heart, February 1, 2002; 87(2): 162 - 168.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
K. Iwakura, H. Ito, S. Kawano, Y. Shintani, K. Yamamoto, A. Kato, M. Ikushima, K. Tanaka, M. Kitakaze, M. Hori, et al.
Predictive factors for development of the no-reflow phenomenon in patients with reperfused anterior wall acute myocardial infarction
J. Am. Coll. Cardiol., August 1, 2001; 38(2): 472 - 477.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
R. K. Kharbanda, M. Peters, B. Walton, M. Kattenhorn, M. Mullen, N. Klein, P. Vallance, J. Deanfield, and R. MacAllister
Ischemic Preconditioning Prevents Endothelial Injury and Systemic Neutrophil Activation During Ischemia-Reperfusion in Humans In Vivo
Circulation, March 27, 2001; 103(12): 1624 - 1630.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
C Mazenot, L Loufrani, D Henrion, C Ribuot, W Muller-Esterl, and D Godin-Ribuot
Endothelial kinin B1-receptors are induced by myocardial ischaemia-reperfusion in the rabbit
J. Physiol., January 1, 2001; 530(1): 69 - 78.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
S. ZAHLER, C. KUPATT, and B. F. BECKER
Endothelial preconditioning by transient oxidative stress reduces inflammatory responses of cultured endothelial cells to TNF-{alpha}
FASEB J, March 1, 2000; 14(3): 555 - 564.
[Abstract] [Full Text]


Home page
Cardiovasc ResHome page
M. Nakamura, N.-P. Wang, Z.-Q. Zhao, J. N Wilcox, V. Thourani, R. A Guyton, and J. Vinten-Johansen
Preconditioning decreases Bax expression, PMN accumulation and apoptosis in reperfused rat heart
Cardiovasc Res, February 1, 2000; 45(3): 661 - 670.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
J.-F. Bouchard, J. Chouinard, and D. Lamontagne
Participation of prostaglandin E2 in the endothelial protective effect of ischaemic preconditioning in isolated rat heart
Cardiovasc Res, January 14, 2000; 45(2): 418 - 427.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
M. Marzilli and M. Mariani
Acute myocardial infarcation: new protagonists and new challenges
Eur. Heart J., December 1, 1999; 20(23): 1691 - 1692.
[PDF]


Home page
Eur Heart JHome page
D Karila-Cohen, D Czitrom, E Brochet, M Faraggi, P Seknadji, D Himbert, J.-M Juliard, P Assayag, and P.G Steg
Decreased no-reflow in patients with anterior myocardial infarction and pre-infarction angina
Eur. Heart J., December 1, 1999; 20(23): 1724 - 1730.
[Abstract] [PDF]


Home page
Cardiovasc ResHome page
F. A. Recchia, P. I. McConnell, K. E. Loke, X. Xu, M. Ochoa, and T. H. Hintze
Nitric oxide controls cardiac substrate utilization in the conscious dog
Cardiovasc Res, November 1, 1999; 44(2): 325 - 332.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
S. A. Thomas, J. A. Fallavollita, T.-C. Lee, J. Feng, and J. M. Canty Jr
Absence of Troponin I Degradation or Altered Sarcoplasmic Reticulum Uptake Protein Expression After Reversible Ischemia in Swine
Circ. Res., September 3, 1999; 85(5): 446 - 456.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
N. Matsuda, K. G. Morgan, and F. W. Sellke
PRECONDITIONING IMPROVES CARDIOPLEGIA-RELATED CORONARY MICROVASCULAR SMOOTH MUSCLE HYPERCONTRACTILITY: ROLE OF KATP CHANNELS
J. Thorac. Cardiovasc. Surg., September 1, 1999; 118(3): 438 - 445.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
P. Beauchamp, V. Richard, F. Tamion, F. Lallemand, J.-P. Lebreton, H. Vaudry, M. Daveau, and C. Thuillez
Protective Effects of Preconditioning in Cultured Rat Endothelial Cells : Effects on Neutrophil Adhesion and Expression of ICAM-1 After Anoxia and Reoxygenation
Circulation, August 3, 1999; 100(5): 541 - 546.
[Abstract] [Full Text] [PDF]


Home page
SEMIN CARDIOTHORAC VASC ANESTHHome page
H.-S. V. Chen, S. C. Body, and S. K. Shernan
Myocardial Preconditioning: Characteristics, Mechanisms, and Clinical Applications
Seminars in Cardiothoracic and Vascular Anesthesia, July 1, 1999; 3(2): 85 - 97.
[Abstract] [PDF]


Home page
Cardiovasc ResHome page
D. Gattullo, R. J. Linden, G. Losano, P. Pagliaro, and N. Westerhof
Ischaemic preconditioning changes the pattern of coronary reactive hyperaemia in the goat: role of adenosine and nitric oxide
Cardiovasc Res, April 1, 1999; 42(1): 57 - 64.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
V. H. Thourani, M. Nakamura, I. G. Duarte, B. L. Bufkin, Z.-Q. Zhao, J. E. Jordan, S. T. Shearer, R. A. Guyton, and J. Vinten-Johansen
ISCHEMIC PRECONDITIONING ATTENUATES POSTISCHEMIC CORONARY ARTERY ENDOTHELIAL DYSFUNCTION IN A MODEL OF MINIMALLY INVASIVE DIRECT CORONARY ARTERY BYPASS GRAFTING
J. Thorac. Cardiovasc. Surg., February 1, 1999; 117(2): 383 - 389.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
J.-F. Bouchard and D. Lamontagne
Protection afforded by preconditioning to the diabetic heart against ischaemic injury
Cardiovasc Res, January 1, 1998; 37(1): 82 - 90.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
N. Kaeffer, V. Richard, and C. Thuillez
Delayed Coronary Endothelial Protection 24 Hours After Preconditioning : Role of Free Radicals
Circulation, October 7, 1997; 96(7): 2311 - 2316.
[Abstract] [Full Text]


Home page
Circ. Res.Home page
E. Giannella, H.-C. Mochmann, and R. Levi
Ischemic Preconditioning Prevents the Impairment of Hypoxic Coronary Vasodilatation Caused by Ischemia/Reperfusion : Role of Adenosine A1/A3 and Bradykinin B2 Receptor Activation
Circ. Res., September 19, 1997; 81(3): 415 - 422.
[Abstract] [Full Text]


Home page
Circ. Res.Home page
X. Zhou, X. Zhai, and M. Ashraf
Preconditioning of Bovine Endothelial Cells : The Protective Effect Is Mediated by an Adenosine A2 ReceptorThrough a Protein Kinase C Signaling Pathway
Circ. Res., January 1, 1996; 78(1): 73 - 81.
[Abstract] [Full Text]


Home page
Ann. Thorac. Surg.Home page
E. A. Bukhari, I. B. Krukenkamp, P. G. Burns, G. R. Gaudette, J. J. Schulman, M. R. Al-Fagih, and S. Levitsky
Does Aprotinin Increase the Myocardial Damage in the Setting of Ischemia and Preconditioning?
Ann. Thorac. Surg., August 1, 1995; 60(2): 307 - 310.
[Abstract] [Full Text]


Home page
CirculationHome page
I. A. Alhaddad, L. Tkaczevski, F. Siddiqui, R. Mir, and E. J. Brown Jr
Aspirin Enhances the Benefits of Late Reperfusion on Infarct Shape : A Possible Mechanism of the Beneficial Effects of Aspirin on Survival After Acute Myocardial Infarction
Circulation, June 1, 1995; 91(11): 2819 - 2823.
[Abstract] [Full Text]


Home page
Circ. Res.Home page
P. G. McLean, D. Aston, D. Sarkar, and A. Ahluwalia
Protease-Activated Receptor-2 Activation Causes EDHF-Like Coronary Vasodilation: Selective Preservation in Ischemia/Reperfusion Injury: Involvement of Lipoxygenase Products, VR1 Receptors, and C-Fibers
Circ. Res., March 8, 2002; 90(4): 465 - 472.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
S.-J. Kim, R. K. Kudej, A. Yatani, Y.-K. Kim, G. Takagi, R. Honda, D. A. Colantonio, J. E. Van Eyk, D. E. Vatner, R. L. Rasmusson, et al.
A Novel Mechanism for Myocardial Stunning Involving Impaired Ca2+ Handling
Circ. Res., October 26, 2001; 89(9): 831 - 837.
[Abstract] [Full Text] [PDF]